Phosphatidylcholine
Both can contribute to TMAO production via gut bacterial metabolism; clinical relevance is debated.
Recommendation: Monitor TMAO if cardiovascular risk is a concern. Routine use is generally well tolerated.
Amino Acid ·Moderate evidence ·Reviewed May 2026
Transports long-chain fatty acids into mitochondria for energy production.
The bottom line
Evidence rating moderate. Most-documented uses: fat metabolism, energy production, exercise recovery. 17 sources indexed (2013–2025), with 8 interaction records on file.
Core mechanism
Shuttles acyl groups across the inner mitochondrial membrane via the carnitine palmitoyltransferase (CPT) system, enabling beta-oxidation of fatty acids for ATP production.
Ranked by evidence and value.
Real-world pricing across three quality tiers. Assumes L-Carnitine L-Tartrate.
Assumes 500-2,000 mg/day. Vendor basis: NOW/iHerb, Vitacost, BulkSupplements powder, and Amazon marketplace; tablets and liquid formats price higher. Updated 2026-05-28.
How much you'd eat to match a supplemental dose.
Red meat is the densest common food source, but supplement doses remain much more concentrated.
What to test, the optimal window inside the conventional range, and how long a response takes.
L-carnitine (500 to 3000 mg per day) raises free and total serum carnitine; tartrate, fumarate, and acetyl forms have differing pharmacokinetics.1,2
Carnitine panel (free, total, acylcarnitine ratio) gives the full picture. Acyl/free ratio above 0.4 suggests metabolic stress.
L-Carnitine may modestly lower ALT in some people with non-alcoholic fatty liver disease (NAFLD), possibly by supporting fatty-acid transport into mitochondria and reducing hepatocellular lipid stress, though this mechanism is not firmly established in humans. Several randomized trials in NAFLD have reported improved transaminases, but the overall evidence is moderate and not yet definitive, so do not expect a meaningful shift in someone whose liver enzymes are already in a healthy range.1,2
Measure ALT on a routine liver panel. Fasting is not strictly required for ALT, but vigorous exercise in the day or two before the draw can transiently raise it, so avoid that for a cleaner baseline. Timing relative to your carnitine dose does not matter for the result. Establish a baseline before starting, then recheck after about 12 weeks while pairing supplementation with the dietary and lifestyle changes that drive most of the benefit. Because ALT reflects liver health and any NAFLD diagnosis is a medical condition, interpret trends with a clinician rather than acting on a single value, and seek prompt review if values rise rather than fall.
Where this appears in the symptom-to-supplement map, ranked by relevance.
Carnitine improves oxygen-limited muscle energy metabolism, which trials link to longer pain-free and maximal walking distance.
Adjunct to medical care; supervised walking programs and prescribed therapy remain first-line, so coordinate with your vascular clinician.
L-carnitine fuels sperm energy metabolism and motility, with several trials showing improved motility in men with poor parameters.1,2
Best paired with antioxidant support rather than used alone.
L-carnitine shuttles long-chain fatty acids into mitochondria for oxidation and may produce small reductions in body weight in meta-analyses.6,12
Effects are modest and only meaningful alongside diet and exercise, not as a standalone fat burner.
L-carnitine shuttles long-chain fatty acids into mitochondria for energy production, and supplementation may help fatigue when levels are low.1,2
Evidence is strongest in older adults and specific deficiency states rather than the general population.
By facilitating mitochondrial fatty acid transport and beta-oxidation, L-carnitine may modestly reduce circulating triglycerides in some populations.7
Evidence is mixed, and gut conversion to TMAO is a theoretical cardiovascular concern that is still under study.
Carnitine shuttles fatty acids into muscle mitochondria for energy, the same pathway that statins can perturb.10,11
Largely mechanistic for this use; speak with your clinician before adding it, especially if you have cardiovascular or kidney disease.
Carnitine supports cardiac fatty acid oxidation; small RCT evidence in cardiomyopathy.10,1
Most useful in deficiency states (hemodialysis, certain cardiomyopathies).
L-carnitine supports fatty acid metabolism and has shown small HDL increases in some metabolic and dialysis populations.7,11
Evidence is mixed and population-dependent; not a substitute for lifestyle change and a clinician-reviewed lipid plan.
Evidence-based stacks that include it, with the exact dose and timing each one uses.
L-Carnitine is highly concentrated in the epididymis and helps shuttle fatty acids into sperm mitochondria for energy, a role linked to sperm motility. Several controlled trials report improved motility, but evidence for higher pregnancy rates is limited.1,2
L-Carnitine helps shuttle long chain fatty acids into the mitochondria where they are burned for energy, so supplementation may modestly support fat oxidation, most plausibly in people with lower baseline levels. Evidence for added benefit in well-nourished people is mixed, and there is limited evidence it could blunt thyroid hormone action, so use caution if you have hypothyroidism.1,2
Pathogenic SLC22A5 variants cause primary carnitine deficiency, a medical condition where carnitine replacement is genotype-directed (PMID 22420015).
Recommendation: Do not use consumer carnitine dosing as a substitute for care of suspected or confirmed primary carnitine deficiency.
Genome-wide work links trimethylamine N-oxide biology to choline and L-carnitine metabolism, including FMO3-related pathways (PMID 24675659).
Recommendation: If trimethylaminuria, high TMAO concern, or strong cardiovascular risk is present, review carnitine use with a clinician.
Both can contribute to TMAO production via gut bacterial metabolism; clinical relevance is debated.
Recommendation: Monitor TMAO if cardiovascular risk is a concern. Routine use is generally well tolerated.
L-carnitine supports transport of fatty acids into mitochondria for oxidation, which is mechanistically complementary to CLA's role in fat metabolism.
Recommendation: Reasonable to combine for body composition goals. No timing precautions; both are generally well tolerated.
The pair supports complementary stages of mitochondrial energy production, with L-Carnitine increasing fatty acid delivery into mitochondria and CoQ10 improving the efficiency of converting that fuel into ATP.
Recommendation: Reasonable to take together, with or without food, for fatigue, exercise capacity, or mitochondrial support. Typical doses are CoQ10 100 to 200mg per day and L-Carnitine 1 to 2g per day. A migraine prophylaxis trial used both concurrently.
L-Carnitine and alpha-lipoic acid are a classic mitochondrial-support pairing. Animal aging studies (notably the Ames and Hagen group work using the acetyl form with lipoic acid) and human trials in coronary artery disease have shown the combination improves mitochondrial enzyme activity, endothelial function, and markers of oxidative stress beyond what either supplies individually. The interaction is favorable and additive rather than risky.
Recommendation: These can be taken together intentionally for mitochondrial and metabolic support. A common pairing is L-Carnitine 1,000 to 2,000 mg/day with alpha-lipoic acid 300 to 600 mg/day, ideally split with meals. Take alpha-lipoic acid roughly 30 minutes before or 2 hours after food if maximizing its absorption matters, and separate it from any mineral supplements (it can chelate some metals). No safety conflict, but monitor blood sugar if you are diabetic since alpha-lipoic acid can mildly lower glucose.
Combining L-Carnitine with Acetyl-L-Carnitine is largely redundant because they draw on and replenish the same carnitine pool. The main practical difference is that ALCAR crosses the blood-brain barrier more readily (favoring cognitive/neural use) while plain L-Carnitine is used more for peripheral fatty-acid oxidation. Taking both is not harmful, but the doses count toward one cumulative carnitine intake rather than two, which matters for total-dose and TMAO considerations.
Recommendation: Usually pick the form that matches your goal rather than stacking: L-Carnitine (1,000 to 2,000 mg/day) for energy/exercise/peripheral metabolism, or Acetyl-L-Carnitine (500 to 2,000 mg/day) for cognitive support. If you do use both, count the combined amount as your total carnitine dose (aim to keep the total in a sensible range, commonly under about 2 to 3 g/day) rather than dosing each separately at full strength. No timing separation is needed.
L-carnitine is used clinically to address valproic acid-associated carnitine depletion, hyperammonemia, and toxicity risk. Valproic acid can shift mitochondrial metabolism toward toxic metabolites and impair ammonia handling, causing confusion, vomiting, lethargy, or encephalopathy in susceptible patients. This is most important with high valproate levels, overdose, liver disease, young age, poor nutrition, urea-cycle disorders, or unexplained mental-status changes.
Recommendation: Do not self-treat suspected valproic acid toxicity with over-the-counter L-carnitine alone. Seek urgent medical care for confusion, severe sleepiness, repeated vomiting, or sudden neurologic changes while on valproic acid. If your prescriber recommends L-carnitine, use the exact dose and continue ammonia, liver-function, valproate-level, and symptom monitoring as directed.
L-Carnitine supports fatty-acid oxidation in cardiomyocytes and modestly lowers diastolic blood pressure. In heart failure patients on carvedilol, L-carnitine has been used adjunctively to improve cardiac energetics and exercise tolerance.
Recommendation: L-Carnitine 1-2 g/day is generally compatible with carvedilol and may provide additional cardiac support. Discuss with your cardiologist before starting, especially if you have heart failure.
L-Carnitine modestly lowers diastolic blood pressure and supports cardiac fatty-acid oxidation. Adjunctive use with metoprolol in heart failure or post-MI patients is generally beneficial, though the BP effect can rarely be additive.
Recommendation: L-Carnitine 1-2 g/day is compatible with metoprolol and may add cardiovascular benefit. Discuss with your cardiologist before starting, particularly if you have heart failure.
Numbered references. Citations throughout the page link here.
Ma X, Yang Y, Liu S et al.. Meta-analysis of the efficacy and safety of L-carnitine and N-acetylcysteine monotherapy for male idiopathic infertility. Revista internacional de andrologia. 2025
Liu A, Cai Y, Yuan Y et al.. Efficacy and safety of carnitine supplementation on NAFLD: a systematic review and meta-analysis. Systematic reviews. 2023
Salles C, Freitas MC, Cruz MME. Impact of L-carnitine in narcolepsy treatment: a systematic review on the effectiveness and safety. Sleep science (Sao Paulo, Brazil). 2022
Weng Y, Zhang S, Huang W et al.. Efficacy of L-Carnitine for Dilated Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials. BioMed research international. 2021
Meta-analysis of 37 RCTs found L-carnitine supplementation significantly decreased body weight, BMI, and fat mass.
L-carnitine supplementation significantly improved multiple metabolic syndrome biomarkers including fasting glucose, triglycerides, HDL cholesterol, and systolic blood pressure.
Askarpour M, Hadi A, Miraghajani M et al.. Beneficial effects of l-carnitine supplementation for weight management in overweight and obese adults: An updated systematic review and dose-response meta-analysis of randomized controlled trials. Pharmacological research. 2020
Meta-analysis of 17 RCTs (1,625 CHF patients) found L-carnitine associated with improved LVEF, stroke volume, cardiac output, and BNP levels.
Elevated TMAO concentrations associated with 1.62x higher risk for major adverse cardiovascular events; L-carnitine precursors associated with ~1.3-1.4x higher risk.
Pooyandjoo M, Nouhi M, Shab-Bidar S et al.. The effect of (L-)carnitine on weight loss in adults: a systematic review and meta-analysis of randomized controlled trials. Obesity reviews : an official journal of the International Association for the Study of Obesity. 2016
L-carnitine associated with 27% reduction in all-cause mortality, 65% reduction in ventricular arrhythmias, and 40% reduction in angina development following MI.
Oral L-carnitine supplementation significantly increased plasma TMAO but no lipid profile changes or atherosclerosis markers detected in healthy aged women over 24 weeks.
Systematic review of 11 studies found L-carnitine supplementation improves body strength, sports endurance, exercise capacity, and delays onset of fatigue.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.